483
L'Oreal USA Products IncFDA 483 - L'Oreal USA Products Inc - December 04, 2012
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
L'Oreal USA Products Inc, an OTC drug product manufacturer in Somerset, NJ, was inspected by the FDA and cited for a significant quality control issue. The firm failed to thoroughly review unexplained discrepancies, specifically concerning multiple preservative system failures in various OTC SPF products. This included not consistently identifying specific root causes or implementing systemic corrective actions for these recurring problems.
Open in Dashboard
ID · f3fce4d8-c98d-487b-8b0f-2ad6ef280ee2